Washington - Enhanced photorejuvenation, using photodynamic therapy (PDT) to simultaneously treat actinic keratoses (AKs) and photodamage, has been associated with encouraging results in the hands of a number of investigators. However, results are being awaited from ongoing controlled studies that hopefully will identify treatment parameters for optimizing safety and efficacy, said Robert A. Weiss, M.D., at the annual meeting of the American Academy of Dermatology here.
Explore trending plant oils in skincare and haircare, plus 2026’s hottest actives like ectoin and hypochlorous acid—balancing glow, barrier repair, and irritation risks.
Preview the trial data dermatology NPs and PAs will dissect in small-group sessions on AD, psoriasis, and type 2 disease at Horizons in Advanced Practice.
The 3rd annual meeting in Atlanta gives dermatology NPs and PAs 4 case-based breakout sessions and a general education session in a focused, small-group setting.
Shannon Trotter, DO, moderated a Dermatology Times Case-Based Roundtable event on how pharmacokinetics, adverse event timing, and trial response criteria should shape hedgehog pathway inhibitor selection in advanced BCC.